Morgan Stanley Ptc Therapeutics, Inc. Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,073,817 shares of PTCT stock, worth $54.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,073,817

Previous 1,158,054 7.27%

Holding current value

$54.7 Million

Previous $43 Million 12.82%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$34.99 - $52.07 $2.95 Million - $4.39 Million	-84,237 Reduced 7.27%	1,073,817 $48.5 Million
Q3 2024 Nov 14, 2024	SELL	$30.39 - $37.66 $10.9 Million - $13.5 Million	-358,703 Reduced 23.65%	1,158,054 $43 Million
Q2 2024 Oct 17, 2024	SELL	$24.69 - $40.12 $13.5 Million - $21.9 Million	-546,284 Reduced 26.48%	1,516,757 $46.4 Million
Q2 2024 Aug 14, 2024	SELL	$24.69 - $40.12 $13.5 Million - $21.9 Million	-546,284 Reduced 26.48%	1,516,757 $46.4 Million
Q1 2024 Oct 17, 2024	BUY	$24.15 - $31.95 $13.2 Million - $17.5 Million	546,284 Added 36.02%	2,063,041 $60 Million
Q1 2024 Aug 16, 2024	BUY	$24.15 - $31.95 $19.7 Million - $26.1 Million	816,782 Added 65.54%	2,063,041 $60 Million
Q1 2024 May 15, 2024	BUY	$24.15 - $31.95 $19.7 Million - $26.1 Million	816,782 Added 65.54%	2,063,041 $60 Million
Q4 2023 Aug 16, 2024	SELL	$18.07 - $29.37 $4.89 Million - $7.94 Million	-270,498 Reduced 17.83%	1,246,259 $34.3 Million
Q4 2023 Feb 13, 2024	BUY	$18.07 - $29.37 $14.6 Million - $23.8 Million	810,519 Added 186.01%	1,246,259 $34.3 Million
Q3 2023 Nov 15, 2023	BUY	$22.41 - $41.99 $1.23 Million - $2.3 Million	54,664 Added 14.34%	435,740 $9.76 Million
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $6.27 Million - $9.17 Million	155,186 Added 68.7%	381,076 $15.5 Million
Q1 2023 May 15, 2023	SELL	$38.16 - $48.86 $2.74 Million - $3.51 Million	-71,775 Reduced 24.11%	225,890 $10.9 Million
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $449,838 - $735,062	13,416 Added 4.72%	297,665 $11.4 Million
Q3 2022 Nov 14, 2022	SELL	$41.85 - $53.85 $5.86 Million - $7.55 Million	-140,138 Reduced 33.02%	284,249 $14.3 Million
Q2 2022 Oct 27, 2022	BUY	$25.6 - $45.23 $2.07 Million - $3.66 Million	80,853 Added 23.54%	424,387 $17 Million
Q2 2022 Aug 15, 2022	BUY	$25.6 - $45.23 $2.07 Million - $3.66 Million	80,853 Added 23.54%	424,387 $17 Million
Q1 2022 Oct 27, 2022	SELL	$33.33 - $44.6 $2.69 Million - $3.61 Million	-80,853 Reduced 19.05%	343,534 $12.8 Million
Q1 2022 May 13, 2022	BUY	$33.33 - $44.6 $4.26 Million - $5.7 Million	127,819 Added 59.25%	343,534 $12.8 Million
Q4 2021 Feb 14, 2022	BUY	$35.36 - $41.86 $6.14 Million - $7.27 Million	173,765 Added 414.22%	215,715 $8.59 Million
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $1.55 Million - $1.88 Million	41,950 New	41,950 $1.56 Million

Others Institutions Holding PTCT

# of Institutions

257

Shares Held

77.3M

Call Options Held

179K

Put Options Held

536K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.65B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account